AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$15.72
+3.22% today
Updated 2026-05-11
Market cap
$2.02B
P/E ratio
7.28
P/S ratio
6.78x
EPS (TTM)
$2.16
Dividend yield
—
52W range
$7 – $17
Volume
1.2M
Aurinia Pharmaceuticals Inc (AUPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.72
12-Month target
$17.96
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 7.28x (capped 25x) · Margin: 100.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.